18+ Male or Female

The trial is being conducted to determine the efficacy (how well the drug works in helping you lose weight) of CagriSema (Cagrilinitide and Semaglutide combined) vs. either Cagrilintide, FDA approved Semaglutide (Wegovy), or placebo (no active ingredient).

Eligibility

• Must be willing to self-inject (inject the medication yourself)
• Must be EXTREMELY motivated and able to attend MULTIPLE appointments over 3 1/2 years
• Must NOT have a diagnosis of Type I diabetes, Type II diabetes, or pre-diabetes
• Must NOT be taking weight loss medications/supplements
• Must NOT have had a previous weight loss surgery

Trial Duration

The trial will last up to 3 1/2 years involving up to 19 visits to our office

Compensation

You will be paid $60 per completed office appointment